Polyglycerol Sebacate/polycaprolactone/reduced Graphene Oxide Composite Scaffold for Myocardial Tissue Engineering

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Oct 14

PMID 39398017

Authors

Azadeh Rejali

Mehdi Ebrahimian-Hosseinabadi

Anousheh Zargar Kharazi

Affiliations

Soon will be listed here.

Abstract

The aim of this research was to fabricate and evaluate polyglycerol sebacate/polycaprolactone/reduced graphene oxide (PGS-PCL-RGO) composite scaffolds for myocardial tissue engineering. Polyglycerol sebacate polymer was synthesized using glycerol and sebacic acid prepolymers, confirmed by Fourier-transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD). Six PGS-PCL-RGO composite scaffolds (S-S) with various weight ratios were prepared in chloroform (CF) and acetone (Ace) solvents at 8 CF:2Ace and 9 CF:1Ace volume ratios, using the electrospinning method at a rate of 1 ml/h and a voltage of 18 kV. The scaffolds' chemical composition and microstructure were characterized by FTIR, XRD, and scanning electron microscopy (SEM). Further investigations included tensile testing, contact angle testing, four-point probe testing for electrical conductivity, degradation testing, and cytotoxicity testing (MTT). The results showed that adding 2%wt RGO to the composite scaffold decreased fiber diameter and degradation rate, while increasing electrical conductivity and ductility. The 33%PGS-65%PCL-2%RGO (S) composite scaffold exhibited the lowest degradation rate (23.87 % over 60 days) and the highest electrical conductivity (51E-3 S/m). Mechanical evaluations revealed an elastic modulus of 2.46 MPa and elongation of 62.43 %, aligning closely with the heart muscle's elastomeric properties. The contact angle test indicated that the scaffold was hydrophilic, with a water contact angle of 61 ± 2°. Additionally, the cell toxicity test confirmed that scaffolds containing RGO were non-toxic and supported good cell viability. In conclusion, the 33%PGS-65%PCL-2%RGO composite scaffold exhibits mechanical and structural properties similar to heart tissue, making it an ideal candidate for myocardial tissue engineering.

References

Sant S, Iyer D, Gaharwar A, Patel A, Khademhosseini A . Effect of biodegradation and de novo matrix synthesis on the mechanical properties of valvular interstitial cell-seeded polyglycerol sebacate-polycaprolactone scaffolds. Acta Biomater. 2012; 9(4):5963-73. PMC: 3662231. DOI: 10.1016/j.actbio.2012.11.014. View

Muylaert D, Fledderus J, Bouten C, Dankers P, Verhaar M . Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds. Heart. 2014; 100(23):1825-30. DOI: 10.1136/heartjnl-2014-306092. View

Kerativitayanan P, Gaharwar A . Elastomeric and mechanically stiff nanocomposites from poly(glycerol sebacate) and bioactive nanosilicates. Acta Biomater. 2015; 26:34-44. DOI: 10.1016/j.actbio.2015.08.025. View

Gerlier D, Thomasset N . Use of MTT colorimetric assay to measure cell activation. J Immunol Methods. 1986; 94(1-2):57-63. DOI: 10.1016/0022-1759(86)90215-2. View

Rai R, Tallawi M, Frati C, Falco A, Gervasi A, Quaini F . Bioactive electrospun fibers of poly(glycerol sebacate) and poly(ε-caprolactone) for cardiac patch application. Adv Healthc Mater. 2015; 4(13):2012-25. DOI: 10.1002/adhm.201500154. View

Sundback C, Shyu J, Wang Y, Faquin W, Langer R, Vacanti J . Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials. 2005; 26(27):5454-64. DOI: 10.1016/j.biomaterials.2005.02.004. View

Schroeder M, Swietach P, Atherton H, Gallagher F, Lee P, Radda G . Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy study. Cardiovasc Res. 2009; 86(1):82-91. PMC: 2836261. DOI: 10.1093/cvr/cvp396. View

Monteiro L, Vasques-Novoa F, Ferreira L, Pinto-do-O P, Nascimento D . Restoring heart function and electrical integrity: closing the circuit. NPJ Regen Med. 2018; 2:9. PMC: 5665620. DOI: 10.1038/s41536-017-0015-2. View

Wu Z, Li Q, Wang L, Zhang Y, Liu W, Zhao S . A novel biomimetic nanofibrous cardiac tissue engineering scaffold with adjustable mechanical and electrical properties based on poly(glycerol sebacate) and polyaniline. Mater Today Bio. 2023; 23:100798. PMC: 10518490. DOI: 10.1016/j.mtbio.2023.100798. View

10.

Gil-Cabrerizo P, Scacchetti I, Garbayo E, Blanco-Prieto M . Cardiac tissue engineering for myocardial infarction treatment. Eur J Pharm Sci. 2023; 185:106439. DOI: 10.1016/j.ejps.2023.106439. View

11.

Liang S, Yang X, Fang X, Cook W, Thouas G, Chen Q . In vitro enzymatic degradation of poly (glycerol sebacate)-based materials. Biomaterials. 2011; 32(33):8486-96. DOI: 10.1016/j.biomaterials.2011.07.080. View

12.

Xu C, Yang K, Xu Y, Meng X, Zhou Y, Xu Y . Melt-electrowriting-enabled anisotropic scaffolds loaded with valve interstitial cells for heart valve tissue Engineering. J Nanobiotechnology. 2024; 22(1):378. PMC: 11212200. DOI: 10.1186/s12951-024-02656-5. View

13.

Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M . Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2015; 133(4):e38-360. DOI: 10.1161/CIR.0000000000000350. View

14.

Heydari P, Varshosaz J, Kharaziha M, Javanmard S . Antibacterial and pH-sensitive methacrylate poly-L-Arginine/poly (β-amino ester) polymer for soft tissue engineering. J Mater Sci Mater Med. 2023; 34(4):16. PMC: 10085925. DOI: 10.1007/s10856-023-06720-8. View

15.

Ravichandran R, Venugopal J, Sundarrajan S, Mukherjee S, Ramakrishna S . Cardiogenic differentiation of mesenchymal stem cells on elastomeric poly (glycerol sebacate)/collagen core/shell fibers. World J Cardiol. 2013; 5(3):28-41. PMC: 3610004. DOI: 10.4330/wjc.v5.i3.28. View

16.

Baheiraei N, Yeganeh H, Ai J, Gharibi R, Azami M, Faghihi F . Synthesis, characterization and antioxidant activity of a novel electroactive and biodegradable polyurethane for cardiac tissue engineering application. Mater Sci Eng C Mater Biol Appl. 2014; 44:24-37. DOI: 10.1016/j.msec.2014.07.061. View

17.

Vunjak Novakovic G, Eschenhagen T, Mummery C . Myocardial tissue engineering: in vitro models. Cold Spring Harb Perspect Med. 2014; 4(3). PMC: 3935388. DOI: 10.1101/cshperspect.a014076. View

18.

He Y, Hou H, Wang S, Lin R, Wang L, Yu L . From waste of marine culture to natural patch in cardiac tissue engineering. Bioact Mater. 2021; 6(7):2000-2010. PMC: 7782558. DOI: 10.1016/j.bioactmat.2020.12.011. View

19.

Coronel R, Wilders R, Verkerk A, Wiegerinck R, Benoist D, Bernus O . Electrophysiological changes in heart failure and their implications for arrhythmogenesis. Biochim Biophys Acta. 2013; 1832(12):2432-41. DOI: 10.1016/j.bbadis.2013.04.002. View

20.

Bagri A, Mattevi C, Acik M, Chabal Y, Chhowalla M, Shenoy V . Structural evolution during the reduction of chemically derived graphene oxide. Nat Chem. 2010; 2(7):581-7. DOI: 10.1038/nchem.686. View